Satisfaction in older patients by geriatric assessment using a novel tablet-based questionnaire system: A cluster-randomized, phase III trial of patients with non-small-cell lung cancer (ENSURE-GA study; NEJ041/CS-Lung001)

被引：0
|
作者：
Soda, Sayo
Mirokuji, Kie
Saito, Ryota
Takamura, Kei
Morita, Ryo
Furuya, Naoki
Kuyama, Shoichi
Shiono, Ayako
Arai, Daisuke
Hosokawa, Shinobu
Masubuchi, Ken
Matsumoto, Naoko
Asahina, Hajime
Kondo, Haruka
Honda, Ryoichi
Hattori, Noboru
Yokoyama, Akihito
Kobayashi, Kunihiko
Isobe, Takeshi
Tsubata, Yukari
机构：
[1] Dokkyo Med Univ, Sch Med, Dept Pulm Med & Clin Immunol, Mibu, Tochigi, Japan
[2] Tokyo Metropolitan Komagome Hosp, Dept Resp Med, Tokyo, Japan
[3] Tohoku Univ, Dept Resp Med, Sendai, Miyagi, Japan
[4] Obihiro Kosei Gen Hosp, Dept Internal Med 1, Obihiro, Hokkaido, Japan
[5] Akita Kousei Med Ctr, Dept Resp Med, Akita, Japan
[6] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp Med, Kawasaki, Kanagawa, Japan
[7] Iwakuni Clin Ctr, Dept Resp Med, Iwakuni, Japan
[8] Saitama Med Univ Int Med Ctr, Dept Resp Med, Saitama, Japan
[9] Saiseikai Utsunomiya Hosp, Dept Pulm Med, Utsunomiya, Tochigi, Japan
[10] Japanese Red Cross Okayama Hosp, Dept Resp Med, Okayama, Japan
[11] Gunma Prefectural Canc Ctr, Dept Pulm Med, Ohta, Gumma, Japan
[12] Hiroshima Red Cross Hosp Hiroshima, Dept Resp Internal Med, Hiroshima, Japan
[13] Atom Bomb Survivors Hosp, Hiroshima, Japan
[14] Hokkaido Univ, Grad Sch Med, Dept Resp Med, Sapporo, Japan
[15] Ehime Prefectural Cent Hosp, Dept Resp Med, Matsuyama, Ehime, Japan
[16] Asahi Gen Hosp, Dept Resp Med, Asahi, Japan
[17] Hiroshima Univ Hosp, Dept Resp Med, Hiroshima, Japan
[18] Kochi Univ, Kochi Med Sch, Dept Resp Med & Allergol, Kochi, Japan
[19] Saitama Med Univ Int Med Ctr, Dept Resp Med, Saitama, Japan
[20] Shimane Univ, Fac Med, Dept Internal Med, Div Med Oncol & Resp Med, Izumo, Shimane, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12041
引用
收藏
页数：1
相关论文
共 26 条
  • [1] Geriatric assessment in older patients with non-small cell lung cancer: Insights from a cluster-randomized, phase III trial-ENSURE-GA study (NEJ041/CS-Lung001)
    Furuya, Naoki
    Kanaji, Nobuhiro
    Yokoo, Keiki
    Yanagawa, Takashi
    Yamamoto, Hiroshi
    Takayama, Koichi
    Kawase, Shigeo
    Matsunaga, Kazuto
    Takeda, Kenichi
    Nagashima, Hiromi
    Sakamoto, Tomohiro
    Hotta, Takamasa
    Takiguchi, Yuichi
    Nogawa, Hitomi
    Nishioka, Yasuhiko
    Kobayashi, Kunihiko
    Isobe, Takeshi
    Tsubata, Yukari
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Protocol for a multi-site, cluster-randomized, phase III, comparative clinical trial of geriatric assessment of older patients with non-small-cell lung cancer: the ENSURE-GA study
    Tsubata, Yukari
    Shinomiya, Shun
    Inoue, Koji
    Ishikawa, Nobuhisa
    Saito, Ryota
    Nakashima, Kazuhisa
    Hotta, Katsuyuki
    Hamada, Akinobu
    Nagashima, Fumio
    Ando, Yuichi
    Morita, Satoshi
    Kobayashi, Kunihiko
    Isobe, Takeshi
    BMC GERIATRICS, 2021, 21 (01)
  • [3] Protocol for a multi-site, cluster‐randomized, phase III, comparative clinical trial of geriatric assessment of older patients with non‐small‐cell lung cancer: the ENSURE-GA study
    Yukari Tsubata
    Shun Shinomiya
    Koji Inoue
    Nobuhisa Ishikawa
    Ryota Saito
    Kazuhisa Nakashima
    Katsuyuki Hotta
    Akinobu Hamada
    Fumio Nagashima
    Yuichi Ando
    Satoshi Morita
    Kunihiko Kobayashi
    Takeshi Isobe
    BMC Geriatrics, 21
  • [4] Chemotherapy for elderly patients with advanced non-small-cell lung cancer:: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial
    Gridelli, C
    Perrone, F
    Gallo, C
    Cigolari, S
    Rossi, A
    Piantedosi, F
    Barbera, S
    Ferraù, F
    Piazza, E
    Rosetti, F
    Clerici, M
    Bertetto, O
    Robbiati, SF
    Frontini, L
    Sacco, C
    Castiglione, F
    Favaretto, A
    Novello, S
    Migliorino, MR
    Gasparini, G
    Galetta, D
    Iaffaioli, RV
    Gebbia, V
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (05): : 362 - 372
  • [5] Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study
    Corre, Romain
    Greillier, Laurent
    Le Caer, Herve
    Audigier-Valette, Clarisse
    Baize, Nathalie
    Berard, Henri
    Falchero, Lionel
    Monnet, Isabelle
    Dansin, Eric
    Vergnenegre, Alain
    Marcq, Marie
    Decroisette, Chantal
    Auliac, Jean-Bernard
    Bota, Suzanna
    Lamy, Regine
    Massuti, Bartomeu
    Dujon, Cecile
    Perol, Maurice
    Daures, Jean-Pierre
    Descourt, Renaud
    Lena, Herve
    Plassot, Carine
    Chouaid, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (13) : 1476 - +
  • [6] Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: The Japanese taxotere lung cancer study group
    Kubota, K
    Watanabe, K
    Kunitoh, H
    Noda, K
    Ichinose, Y
    Katakami, N
    Sugiura, T
    Kawahara, M
    Yokoyama, A
    Yokota, S
    Yoneda, S
    Matsui, K
    Kudo, S
    Shibuya, M
    Isobe, T
    Segawa, Y
    Nishiwaki, Y
    Ohashi, Y
    Niitani, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) : 254 - 261
  • [7] Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study
    Biesma, B.
    Wymenga, A. N. M.
    Vincent, A.
    Dalesio, O.
    Smit, H. J. M.
    Stigt, J. A.
    Smit, E. F.
    van Felius, C. L.
    van Putten, J. W. G.
    Slaets, J. P. J.
    Groen, H. J. M.
    ANNALS OF ONCOLOGY, 2011, 22 (07) : 1520 - 1527
  • [8] PROGNOSTIC FACTORS IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS: DATA FROM THE RANDOMIZED PHASE III STUDY COMPARED GEFITINIB WITH CARBOPLATIN PLUS PACLITAXEL (NEJ002)
    Minegishi, Y.
    Kobayashi, K.
    Maemondo, M.
    Inoue, A.
    Sugawara, S.
    Ohizumi, S.
    Isobe, H.
    Hagiwara, K.
    Morita, S.
    Nukiwa, T.
    Gemma, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 116 - 116
  • [9] A randomized controlled phase III trial protocol: perioperative pirfenidone therapy in patients with non-small-cell lung cancer combined with idiopathic pulmonary fibrosis to confirm the preventative effect against postoperative acute exacerbation: the PIII-PEOPLE study (NEJ034)
    Sakairi, Yuichi
    Yoshino, Ichiro
    Iwata, Takekazu
    Yoshida, Shigetoshi
    Kuwano, Kazuyoshi
    Azuma, Arata
    Sakai, Shuji
    Kobayashi, Kunihiko
    North East Japan Study Group
    JOURNAL OF THORACIC DISEASE, 2023, 15 (03) : 1486 - 1493
  • [10] First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study
    Wu, Y. -L.
    Zhou, C.
    Liam, C. -K.
    Wu, G.
    Liu, X.
    Zhong, Z.
    Lu, S.
    Cheng, Y.
    Han, B.
    Chen, L.
    Huang, C.
    Qin, S.
    Zhu, Y.
    Pan, H.
    Liang, H.
    Li, E.
    Jiang, G.
    How, S. H.
    Fernando, M. C. L.
    Zhang, Y.
    Xia, F.
    Zuo, Y.
    ANNALS OF ONCOLOGY, 2015, 26 (09) : 1883 - 1889
123